Interventional Oncology Market size is set to grow by USD 1.04 bn from 2024-2028, AngioDynamics Inc., Becton Dickinson and Co. & Boston Scientific Corp., and more to emerge as Some of the Key Companies- Technavio

NEW YORK, March 19, 2024 /PRNewswire/ — The global interventional oncology market size is estimated to grow by USD 1.04 bn from 2024 to 2028, according to Technavio. The market is estimated to grow at a CAGR of 7.7% during the forecast period. As a content expert, I’d be happy to provide an industry trend analysis on the Interventional Oncology Market. According to recent research studies, the global incidence of cancer is on the rise, with an estimated 27.5 million new cases expected by 2040. Key stakeholders in this market include cancer therapies providers, MIS surgeries manufacturers, and reimbursement coverage entities. Buying behavior is influenced by the incidence of various tumors, such as lung, liver, and breast cancers, as well as technological advancements in minimally invasive procedures. Public-private investments and assumptions regarding reimbursement coverage also play a significant role in market growth. For a more in-depth analysis, please request a free sample report. Traditional treatment procedures continue to coexist with interventional oncology, offering opportunities for innovation and expansion.

Reports provide in-depth analysis on market dynamics, competitive landscape, market size with historical  (2018 – 2022) and forecasted (2024-2028) data- Request a sample report

Key Company

Interventional Oncology Market  is fragmented ; the companies are competing with competitors and are trying to get greater market share. The market is growing, and the chances of new entrants cannot be overlooked. The major companies have well-established economies of scale and market presence and generally rely on positioning technological advances, and the price of the products. Interventional Oncology Market report includes information on the product launches, sustainability, and prospects of leading vendors including AngioDynamics Inc., Becton Dickinson and Co., Boston Scientific Corp., Cook Group Inc., Elekta AB, HealthTronics Inc., Hologic Inc., IceCure Medical Ltd., INSIGHTEC Ltd., Johnson and Johnson, Medtronic Plc, MedWaves Inc., Merit Medical Systems Inc., Mermaid Medical Group, Profound Medical Corp., Siemens AG, Sirtex Medical Pty Ltd., Teleflex Inc., Terumo Corp., Quantum Surgical SAS .

Key benefits for Companies

The report offers information on the criticality of vendor inputs, including R&D, CAPEX, and technology.It also provides detailed analyses of the market’s competitive landscape and vendors’ product offerings.The report also provides a qualitative and quantitative analysis of vendors to help clients understand the wider business environment as well as the strengths and weaknesses of key market players.Data is qualitatively analyzed to categorize vendors as pure play, category focused, industry focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak. Expand operations in the future.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters.View Sample Report

 Market Segmentation

This Interventional Oncology Market report extensively covers market segmentation by End-user (Hospitals and diagnostic centers, Ambulatory surgery centers, Research and academic institutes) Product (Particle embolization, Ablation, Support devices) Geography (North America, Europe, Asia, Rest of World (ROW))

This report breaks down the global Interventional Oncology Market by segment.list, providing an overview and analyzing market trends. It uses data from 2023 to estimate market figures for 2024 to end-year, offering essential insights into the current size and future growth of the market. Additionally, the report covers market characteristics, major companies, user preferences, and geographic opportunities. Regions covered include North America, Europe, Asia-Pacific, and RoW (South America, the Middle East, and Africa). 
The report also covers information segments with regional analysis; estimates and forecast 2024- 2028 (USD Billion). Explore detailed information by.purchasing a report

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product Type
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Company Landscape
12 Company Analysis
13 Appendix

About US

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/interventional-oncology-market-size-is-set-to-grow-by-usd-1-04-bn-from-2024-2028–angiodynamics-inc-becton-dickinson-and-co–boston-scientific-corp-and-more-to-emerge-as-some-of-the-key-companies–technavio-302091299.html

SOURCE Technavio